Profound Medical Corp (TSX:PRN)
C$ 10.15 -0.03 (-0.29%) Market Cap: 248.49 Mil Enterprise Value: 211.28 Mil PE Ratio: 0 PB Ratio: 4.62 GF Score: 75/100

Profound Medical Corp at Cowen Health Care Conference Transcript

Mar 08, 2023 / 02:10PM GMT
Release Date Price: C$15.07 (-4.56%)
Arun Menawat
Profound Medical Corp. - CEO & Chairman of the Board

My name is Arun Menawat. I'm the CEO of Profound Medical. And I'm delighted to be at this conference. And since it's 9:10, let's get started to talk about our interesting company.

So Profound is really bringing a game-changing technology to the market. And so you can see incision-free ablative interventions. And we use real-time MRI in our imaging as part of our imaging. So very strong with imaging as a partner technology for us.

Our first product is for ablation of prostate. So we are primarily in prostate cancer today. I'll just quickly go through what the disease looks like. So prostate typically is actually one of the largest cancers in men today. And typically, when men get prostate cancer, they either remove the whole prostate or they radiate the prostate. So they don't really worry much about what's inside that prostate.

But it's an intricate organ because you have the urethra, which -- where the water flows through. You also have the seminal vesicles where all the fluids come from the testicular

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot